Develops drugs for inherited nucleotide repeat expansion diseases.
Dec 2025Revenue $0.00/yrExpenses $79.5M/yr
No trendCash runway ≈ 3.8 years from Jun 2026
Figures by year
When will Design Therapeutics be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2025, revenue was $0.00 and expenses $79.5M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $0.00 | $79.5M | −$79.5M |
| Dec 2024 | $0.00 | $62.4M | −$62.4M |
| Dec 2020 | $226K | $8.56M | −$8.33M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.